Dosage and administration
Take One (1) tablet daily or as prescribed by a physician.
Take One (1) tablet daily or as prescribed by a physician.
Prenatal Multivitamin/Multimineral Tablet
| Supplement Facts Serving Size: 1 Tablet | ||
|---|---|---|
| Amount Per Serving | %DV Pregnant and Lactating Women | |
| Vitamin A (Acetate 3600 IU & Beta Carotene 400 IU) | 1200 mcg RAE | 92% |
| Vitamin C (Ascorbic Acid) | 80 mg | 67% |
| Vitamin D (as Cholecalciferol) | 10 mcg (400 IU) | 67% |
| Vitamin E (as dl-Alpha Tocopheryl Acetate) | 7 mg* (15 IU) | 37% |
| Thiamin (as Thiamine Mononitrate) | 1.5 mg | 107% |
| Riboflavin | 1.6 mg | 100% |
| Niacin (as Niacinamide) | 17 mg NE | 94% |
| Vitamin B6 (as Pyridoxine HCl) | 4 mg | 200% |
| Folate (as Folic Acid) | 1667 mcg DFE (1000 mcg folic acid) | 278% |
| Vitamin B12 ( as Cyanocobalamin) | 2.5 mcg | 89% |
| Biotin | 30 mcg | 86% |
| Pantothenic Acid (as Calcium Pantothenate) | 7 mg | 100% |
| Calcium (as Calcium Carbonate) | 200 mg | 15% |
| Iron (as Ferrous Fumarate) | 60 mg | 222% |
| Magnesium (as Magnesium oxide) | 100 mg | 25% |
| Zinc (as Zinc Oxide) | 25 mg | 192% |
| Copper (as Cupric Oxide) | 3 mg | 231% |
* Equal to mg alpha-tocopherol
Other ingredients: Microcrystalline cellulose, potassium citrate, croscarmellose sodium, citric acid, stearic acid, povidone K30, acacia, magnesium stearate, hypromellose, fumed silica, titanium dioxide, polyethylene glycol.
PNV 27-Ca/Fe/FA tablets help assure an adequate intake of the vitamins and minerals listed. Folate supplementation may be recommended for individuals who have higher-than normal demands for folate such as pregnant women.
Supplemental vitamins and minerals should not be prescribed for patients with hemochromatosis or Wilson's disease.
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately. |
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia assessment, such that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia. The calcium content should be considered before prescribing for patients with history of kidney stones. Do not exceed the recommended dose.
Biotin levels higher than the recommended daily allowance may cause interference with some laboratory tests, including cardiovascular diagnostic tests (e.g. troponin) and hormone test, and may lead to incorrect test results. Tell your healthcare provider about all prescription and over-the-counter medicines, vitamins, and dietary supplements that you take, including biotin.
PNV 27-Ca/Fe/FA is not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, Clopidogrel).
Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Take One (1) tablet daily or as prescribed by a physician.
PNV 27-Ca/Fe/FA is an oval shaped, white film-coated tablet debossed "193", supplied in bottles of 100 tablets.
Product Code: 69367-193-01
Store at 20°-25°C (68°-77°F), excursion permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature]. Dispense in a tight, light resistant container as defined in the USP with a child-resistant closure.
KEEP OUT OF REACH OF CHILDREN.
For use on the order of a healthcare practitioner.
To report a serious adverse event contact: 1-844-221-7294
Manufactured for:
Westminster Pharmaceuticals, LLC
Nashville, TN 37217
Rev. 12/24
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| VITAMIN A Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69367-193-01 | PNV 27-Ca/Fe/FA | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69367-193-01 | EA - Each | 69367-193 | a147e1f5-49ce-4a88-acb7-e86df14a3aba | 1 | 2025-06-13 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69367-193 | 69367-193-01 |
Every source-derived ingredient row is available through these pages.
Adverse event summaries are temporarily unavailable. Other product information remains available.